Clinical Trial Search

Primary: To Determine Platelet Inhibition Before and After Switching for Two Weeks From Clopidogrel to Ticagrelor in Patients With CLI. — 173; 140; 71; 63 P2Y12 reaction units…

Primary: Asses the Prevalence of High On-treatment Platelet Reactivity in Critical Limb Ischemia Patients Treated With Aspirin and Clopidogrel. — 18; 17; 8; 57 Participants

Primary: Adherence — 1; 8; 3 millimeters — p=.037

Primary: Number of Patients With Deep Vein Thrombosis for Safety Assessment. — 0; 3; 0; 0 participants

Primary: Residual Limb Hip Muscle Peak Torque at Baseline — 25.6; 14.9; 25.6; 13.1 newton-meters / kg*meters

Primary: "Average" Phantom Limb Pain Intensity 4 Weeks Following Initiation of an Ambulatory Continuous Peripheral Nerve Block (as Measured by the Numeric Rating Scale Within the…

Primary: Incidence of Death From Any Cause or Myocardial Infarction — 123; 129 Participants

Primary: Wound Healing — 30 Participants

Primary: Reintervention, Above Ankle Amputation and Restenosis (RAS) — 7; 4 Participants

Primary: Treatment-Emergent Adverse Events. — 3; 3; 3; 3 Participants

Primary: Primary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, Heart Failure, or Resuscitated Cardiac Arrest…

Primary: Stimulation Thresholds to a Variety of Stimulus Parameters — 2.13 milliamps

Primary: Ratio of Trans-epidermal Water Loss (TEWL) at 16 Weeks After Use — 1.69 ratio — p=<0.05

Primary: Whole-body Angular Momentum in Sagittal-plane; Momentum of the Body in the Sagittal Plane of Walking Progression — 0.025; 0.031; 0.027; 0.028 Unitless (normalized)

Primary: Change of Ankle Brachial Index (ABI) at 6-month Post-procedure. — 0.24; 0.44 ratio